Overview
Location
United States, California, San Diego
Employees
51-200
Founded date
2012
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 8, 2015 | Five (non-cancer) areas Bristol-Myers Squibb is pursuing hard | The pharma giant has indeed found a sweet spot in immuno-oncology. Take a look at the recent success of Opdivo, which was recently forecasted to have a 2019 revenue of $5.68 billion. Beyond that, BMS is interested in pursuing the following ... |
| Sep 18, 2012 | J&J to open innovation centers in London, China, U.S. to hunt for novel, early stage deals | “This is all about catching the wave as it happens,” she said. “The innovation centers allow us to be closer to where the innovation occurs, to access and invest in the best early stage science and technology, and to fuel our business as we... |
| Mar 15, 2012 | Merck research center brings together scientists, entrepreneurs, VCs | Merck (NYSE:MRK) has launched a nonprofit translational research center in San Diego in a move that reflects the dizzy heights of the patent cliffs some Big Pharma companies are facing. The Whitehouse Station, New Jersey company is providin... |
| Merck research center brings together scientists, entrepreneurs, VCs | Merck (NYSE:MRK) has launched a nonprofit translational research center in San Diego in a move that reflects the dizzy heights of the patent cliffs some Big Pharma companies are facing. The Whitehouse Station, New Jersey company is providin... | |
| J&J to open innovation centers in London, China, U.S. to hunt for novel, early stage deals | In a move to gain access to early stage innovation, Johnson & Johnson (NYSE:JNJ) is opening innovation centers in Europe and China as well as in Boston. Earlier this year, its Janssen pharmaceuticals division opened an innovation center... | |
| Five (non-cancer) areas Bristol-Myers Squibb is pursuing hard | Outside of cancer immunotherapy, Bristol-Myers Squibb is interested in pursuing five areas: Heart failure, virology, rare disease, immunoscience and fibrosis. Donnie McGrath, a vp at Bristol-Myers Squibb and head of search and evaluation, d... |